相似文献
1
The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease.
J Alzheimers Dis. 2018;62(3):1241-1245. doi: 10.3233/JAD-170581.
2
Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation.
Alzheimers Res Ther. 2019 Oct 18;11(1):86. doi: 10.1186/s13195-019-0541-9.
3
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.
Aging Cell. 2016 Oct;15(5):914-23. doi: 10.1111/acel.12500. Epub 2016 Jul 12.
4
Key Peptides and Proteins in Alzheimer's Disease.
Curr Protein Pept Sci. 2019;20(6):577-599. doi: 10.2174/1389203720666190103123434.
5
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
Neurosci Lett. 2021 May 29;754:135894. doi: 10.1016/j.neulet.2021.135894. Epub 2021 Apr 10.
6
Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Acta Neuropathol Commun. 2018 Nov 8;6(1):121. doi: 10.1186/s40478-018-0626-x.
7
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nature. 2012 May 2;485(7400):651-5. doi: 10.1038/nature11060.
8
Alzheimer's disease.
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
9
Aβ monomer induces phosphorylation of Tau at Ser-214 through β2AR-PKA-JNK signaling pathway.
FASEB J. 2020 Apr;34(4):5092-5105. doi: 10.1096/fj.201902230RR. Epub 2020 Feb 17.
10
Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Int J Mol Sci. 2020 Oct 9;21(20):7443. doi: 10.3390/ijms21207443.
引用本文的文献
1
Optimal control of monomers and oligomers degradation in an Alzheimer's disease model.
J Math Biol. 2025 Aug 8;91(3):27. doi: 10.1007/s00285-025-02256-3.
2
Mapping the hippocampal spatial proteomic signature in male and female mice of an early Alzheimer's disease model.
Biol Sex Differ. 2025 May 25;16(1):36. doi: 10.1186/s13293-025-00697-5.
3
Photobiomodulation modulates mitochondrial energy metabolism and ameliorates neurological damage in an APP/PS1 mousmodel of Alzheimer's disease.
Alzheimers Res Ther. 2025 Apr 5;17(1):72. doi: 10.1186/s13195-025-01714-w.
4
Expanding horizons in theragnostics: from oncology to multidisciplinary applications.
Radiol Med. 2025 Mar 5. doi: 10.1007/s11547-025-01971-7.
5
Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years.
Neurol Ther. 2024 Dec;13(6):1571-1595. doi: 10.1007/s40120-024-00664-z. Epub 2024 Oct 8.
6
A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease.
Front Aging Neurosci. 2023 Aug 17;15:1213968. doi: 10.3389/fnagi.2023.1213968. eCollection 2023.
7
Exploring the therapeutic efficacy of peptides in ameliorating Alzheimer's disease.
Heliyon. 2023 Apr 11;9(5):e15406. doi: 10.1016/j.heliyon.2023.e15406. eCollection 2023 May.
8
Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer's disease: A systematic review and meta-analysis of animal studies.
Front Pharmacol. 2023 Mar 3;14:1053680. doi: 10.3389/fphar.2023.1053680. eCollection 2023.
9
Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease.
Expert Opin Investig Drugs. 2023 Feb;32(2):89-94. doi: 10.1080/13543784.2023.2178414. Epub 2023 Feb 28.
10
Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer's Disease.
Curr Neuropharmacol. 2023;21(4):787-807. doi: 10.2174/1570159X20666221010113812.
本文引用的文献
1
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.
Aging Cell. 2016 Oct;15(5):914-23. doi: 10.1111/acel.12500. Epub 2016 Jul 12.
2
Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons.
Front Cell Neurosci. 2015 Aug 7;9:297. doi: 10.3389/fncel.2015.00297. eCollection 2015.
3
Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4465-74. doi: 10.1073/pnas.1421182112. Epub 2015 Jul 29.
4
Programmed cell death in aging.
Ageing Res Rev. 2015 Sep;23(Pt A):90-100. doi: 10.1016/j.arr.2015.04.002. Epub 2015 Apr 8.
5
On the lag phase in amyloid fibril formation.
Phys Chem Chem Phys. 2015 Mar 28;17(12):7606-18. doi: 10.1039/c4cp05563b.
6
Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease.
Neurotherapeutics. 2015 Jan;12(1):94-108. doi: 10.1007/s13311-014-0320-z.
7
Aβ1-42 monomers or oligomers have different effects on autophagy and apoptosis.
Autophagy. 2014 Oct 1;10(10):1827-43. doi: 10.4161/auto.30001. Epub 2014 Aug 12.
8
GSK-3β, a pivotal kinase in Alzheimer disease.
Front Mol Neurosci. 2014 May 21;7:46. doi: 10.3389/fnmol.2014.00046. eCollection 2014.
9
Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral.
Cell Tissue Res. 2014 May;356(2):279-86. doi: 10.1007/s00441-013-1789-1. Epub 2014 Feb 5.
10
Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain.
Mol Psychiatry. 2013 Aug;18(8):882-8. doi: 10.1038/mp.2012.115. Epub 2012 Aug 7.
Zotero 插件